[1]
Anand, M.I. et al. 2022. SGLT2 INHIBITORS DECREASE CARDIOVASCULAR DEATH AND HEART FAILURE HOSPITALIZATIONS: A SYSTEMATIC REVIEW . Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425). 8, 11 (Nov. 2022), 7–13.